Abstract:Highlight • The effective integration of machine learning and genetic algorithms to optimize peptide modifications offers a promising avenue for peptide design. • It introduces novel techniques for the directly modification of small peptides, particularly in cases where insufficient data is available for traditional approaches. • It strategically positions the introduction of positive charge amino acids via our model instead of a mere cumulative addition of positive charged amino-acids. • Minimal modifications to the peptide structure can exert a profound influence on the inhibitory activity of LPS-binding peptides. Introduction Antimicrobial peptides (AMPs) are valuable alternatives to traditional antibiotics, possess a variety of potent biological activities and exhibit immunomodulatory effects that alleviate difficult-to-treat infections. Clarifying the structure-activity relationships of AMPs can direct the synthesis of desirable peptide therapeutics. Objectives In this study, the lipopolysaccharide-binding domain (LBD) was identified through machine learning-guided directed evolution, which acts as a functional domain of the anti-lipopolysaccharide factor family of AMPs identified from Marsupenaeus japonicus . Methods LBD A-D was identified as an output of this algorithm, in which the original LBD Mj sequence was the input, and the three-dimensional solution structure of LBD B was determined using nuclear magnetic resonance. Furthermore, our study involved a comprehensive series of experiments, including morphological studies and in vitro and in vivo antibacterial tests. Results The NMR solution structure showed that LBD B possesses a circular extended structure with a disulfide crosslink at the terminus and two 3 10 -helices and exhibits a broad antimicrobial spectrum. In addition, scanning electron microscopy (SEM) and transmission electron microscopy (TEM) showed that LBD B induced the formation of a cluster of bacteria wrapped in a flexible coating that ruptured and consequently killed the bacteria. Finally, coinjection of LBD B , Vibrio alginolyticus and Staphylococcus aureus in vivo improved the survival of M. japonicus , demonstrating the promising therapeutic role of LBD B for treating infectious disease. Conclusions The findings of this study pave the way for the rational drug design of activity-enhanced peptide antibiotics. Graphical abstract Download : Download high-res image (110KB) Download : Download full-size image Employing machine learning and genetic algorithms, we developed structurally enhanced antimicrobial peptides boasting exceptional efficacy.

In silico screening of protein-binding peptides with an application to developing peptide inhibitors against antibiotic resistance

New peptide deformylase inhibitors design, synthesis and pharmacokinetic assessment

Antimicrobial peptides designed by computational analysis of proteomes

In Silico Design of Antimicrobial Oligopeptides Based on 3D-QSAR Modeling and Bioassay Evaluation

An Efficient Evaluation System Accelerates α-Helical Antimicrobial Peptide Discovery and Its Application to Global Human Genome Mining

Peptide-Membrane Docking and Molecular Dynamic Simulation of In Silico Detected Antimicrobial Peptides from Portulaca oleracea's Transcriptome

Design and synthesis of broad-spectrum antimicrobial amphiphilic peptidomimetics to combat drug-resistance

Synthetic molecular evolution of antimicrobial peptides

In silico bioprospecting of receptors for Doderlin: an antimicrobial peptide isolated from Lactobacillus acidophilus

Discovery of Antimicrobial Peptides Targeting Acinetobacter Baumannii Via a Pre-Trained and Fine-Tuned Few-Shot Learning-Based Pipeline

Machine learning and genetic algorithm-guided directed evolution for the development of antimicrobial peptides

Design of highly potent anti-biofilm, antimicrobial peptides using explainable artificial intelligence

In Silico Discovery of Novel Ligands for Antimicrobial Lipopeptides for Computer-Aided Drug Design

Phage Display Technique: A Novel Medicinal Approach to Overcome an Tibiotic Resistance by Using Peptide-Based Inhibitors Against Beta-Lactamases

In silico identification of novel peptides with antibacterial activity against multidrug resistant Staphylococcus aureus

Integrated computational approaches for advancing antimicrobial peptide development

A Combinatorial Yeast Overlay Method for the Isolation of Antibacterial Oligopeptides

An Intelligent Strategy with All-Atom Molecular Dynamics Simulations for the Design of Lipopeptides Against Multidrug-Resistant Pseudomonas Aeruginosa.

ProT‐Diff: A Modularized and Efficient Strategy for De Novo Generation of Antimicrobial Peptide Sequences by Integrating Protein Language and Diffusion Models

In silico-designed antimicrobial peptide targeting MRSA and E. coli with antibacterial and antibiofilm actions

Analysis of modular bioengineered antimicrobial lanthipeptides at nanoliter scale